Cytiva is a global provider of technologies and services that support the development and production of biopharmaceuticals. It focuses on areas such as bioprocessing, cell and gene therapy, and protein purification, helping researchers and manufacturers streamline their processes and improve efficiency. Originally part of GE Healthcare, Cytiva became an independent company in 2020. It offers a wide range of products, including chromatography systems and bioreactors, to assist in the creation of life-saving therapies. With a commitment to innovation, Cytiva plays a crucial role in advancing the biotechnology industry.